| 000 | 01545 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515073535.0 | ||
| 264 | 0 | _c20071206 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a0449-3060 | ||
| 024 | 7 |
_a10.1269/jrr.07014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColquhoun, A J | |
| 245 | 0 | 0 |
_aCombination treatment with ionising radiation and gefitinib ('Iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo. _h[electronic resource] |
| 260 |
_bJournal of radiation research _cSep 2007 |
||
| 300 |
_a351-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGefitinib |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aMchugh, L A | |
| 700 | 1 | _aTulchinsky, E | |
| 700 | 1 | _aKriajevska, M | |
| 700 | 1 | _aMellon, J K | |
| 773 | 0 |
_tJournal of radiation research _gvol. 48 _gno. 5 _gp. 351-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1269/jrr.07014 _zAvailable from publisher's website |
| 999 |
_c17145645 _d17145645 |
||